Pfizer Inc will buy Anacor Pharmaceuticals Inc in a deal valued at $5.2 billion (Rs 34594.3 crore), net of cash, for access to Anacor`s non-steroidal topical gel to treat eczema.
Pfizer will pay $99.25 per share for Anacor, a 55% premium to the stock`s Friday close, the companies said on Monday.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
